2 completed, 1 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
Follow cilofexor: new trials by email Literature Review of cilofexor trials Research Report on cilofexor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis Cilofexor - Primary Sclerosing Cholangitis, Compensated Cirrhosis | Phase 1 | Terminated | Gilead Sciences | 11 | 2019-10-17 | 2023-07-27 |
| Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function Cilofexor - Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC) | Phase 1 | Completed | Gilead Sciences | 57 | 2016-07-13 | 2021-01-07 |
| Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674 (Cilofexor), and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics Cilofexor, Placebo - Nonalcoholic Steatohepatitis (NASH) | Phase 1 | Completed | Gilead Sciences | 120 | 2016-01-20 | 2020-10-12 |
Cholangitis, Sclerosing (2) · Non-alcoholic Fatty Liver Disease (2)
Gilead Sciences (3)
United States (3) · New Zealand (1)